Phase II study of the farnesyl transferase inhibitor R115777 in patients with sensitive relapse small-cell lung cancer

J. V. Heymach, D. H. Johnson, F. R. Khuri, H. Safran, L. L. Schlabach, F. Yunus, R. F. De Vore, P. M. De Porre, H. M. Richards, X. Jia, S. Zhang, B. E. Johnson

Research output: Contribution to journalArticlepeer-review

96 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of the farnesyl transferase inhibitor R115777 in patients with sensitive relapse small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences